This is out Library. Please click on the article title to view the details.
submitted by: admin on 09/20/2013
Newer antidepressants are being promoted as better than the older ones. The bottom line is that when drugs go off patent, the drug companies have a need to convince MDs and the public that they should purchase their newer, more profitable products. There are problems with antidepressants that include increased risk of suicide, osteoporosis, and heart...
submitted by: admin on 09/20/2013
Up to a fifth of patients on SSRI antidepressants do worse than with placebo. There is no way to tell who will do worse. It is interesting that no comparison was made with exercise and no credit was given to placebo in this big pharma sponsored study published in Archives of Psychiatry in December of 2011. Little mention was made of the side effects such as GI...
submitted by: admin on 09/20/2013
Dr. Len and Nurse Vicki review the long list of drugs that have the potential to create cognitive decline in the elderly. The value and importance of lifestyle is highlighted and the lack of effectiveness of drugs to treat cognitive decline is revealed.
submitted by: admin on 09/20/2013
A report from the Montreal Geriatric University Institute in November of 2012 reviewed 68 trials on benzodiazepines, 12 on antihistamines, and 15 on tricyclic antidepressants and concluded that these families of drugs have a significant negative impact on memory and concentration in the elderly. The American Geriatrics Society proclaimed that these...
submitted by: admin on 11/21/2024
Between 30 and 50% of new breast cancer diagnoses are found on mammography screenings and are classified as ductal carcinoma in situ, or DCIS. Most of these "cancers" are not cancer at all. In fact about 97% are benign lesions that can be followed over time quite safely. Most cases of DCIS would be better off under-diagnosed and under-treated.
Unfortunately,...